Editorial: Racial difference in the prognosis of lupus nephritis

Nephrology

Volumn 15, Issue 4, 2010, Pages 480-481

  Mok, Chi Chiu ^a  

^a TUEN MUN HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE;

CREATININE BLOOD LEVEL; DISEASE PREDISPOSITION; EARLY DIAGNOSIS; EDITORIAL; EDUCATIONAL STATUS; GENETIC PREDISPOSITION; HUMAN; KIDNEY DISEASE; LUPUS ERYTHEMATOSUS NEPHRITIS; PATIENT CARE; PATIENT COMPLIANCE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RACE DIFFERENCE; RENAL REPLACEMENT THERAPY; RESOURCE MANAGEMENT; SURVIVAL RATE; SYSTEMIC LUPUS ERYTHEMATOSUS; CHRONIC KIDNEY FAILURE; DISEASE COURSE; ETHNOLOGY; HEALTH DISPARITY; MORTALITY; NOTE; RACE; RISK ASSESSMENT; RISK FACTOR;

CONTINENTAL POPULATION GROUPS; DISEASE PROGRESSION; HEALTH STATUS DISPARITIES; HUMANS; KIDNEY FAILURE, CHRONIC; LUPUS NEPHRITIS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS;

EID: 77952899149     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2010.01318.x     Document Type: Editorial

References (14)

1. Mok CC, Lau CS. Lupus in Hong Kong Chinese. Lupus 2003 12 : 717 722.
2. Mok CC, To CH, Ho LY, Yu KL. Incidence and mortality of systemic lupus erythematosus in a southern Chinese population, 2000-2006. J. Rheumatol. 2008 35 : 1978 1982.
3. Mok CC, Tang SS, To CH, Petri M. Incidence and risk factors of thromboembolism in systemic lupus erythematosus: A comparison of three ethnic groups. Arthritis Rheum. 2005 52 : 2774 2782.
4. Bastian HM, Roseman JM, McGwin G Jr. et al. LUMINA Study Group. LUpus in MInority populations: NAture vs nurture. Systemic lupus erythematosus in three ethnic groups. XII. Risk factors for lupus nephritis after diagnosis. Lupus 2002 11 : 152 160.
5. Mok CC, Ying KY, Ng WL et al. Long-term outcome of diffuse proliferative lupus glomerulonephritis treated with cyclophosphamide. Am. J. Med. 2006 119 : 355.e25 33.
6. Mok CC. Update on emerging drug therapies for systemic lupus erythematosus. Expert Opin. Emerg. Drugs 2010 15 : 53 70.
7. Mok CC. Prognostic factors in lupus nephritis. Lupus 2005 14 : 39 44.
8. Dooley MA, Hogan S, Jennette C, Falk R. Cyclophosphamide therapy for lupus nephritis: Poor renal survival in black Americans. Glomerular Disease Collaborative Network. Kidney Int. 1997 51 : 1188 1195.
9. Ward MM, Pyun E, Studenski S. Long-term survival in systemic lupus erythematosus. Patient characteristics associated with poorer outcomes. Arthritis. Rheum. 1995 38 : 274 283.
10. Barr RG, Seliger S, Appel GB et al. Prognosis in proliferative lupus nephritis: The role of socio-economic status and race/ethnicity. Nephrol. Dial. Transplant. 2003 18 : 2039 2046.
11. Harley JB, Kelly JA, Kaufman KM. Unraveling the genetics of systemic lupus erythematosus. Springer Semin. Immunopathol. 2006 28 : 119 130.
12. Korbet SM, Lewis EJ, Schwartz MM, Reichlin M, Evans J, Rohde RD. Factors predictive of outcome in severe lupus nephritis. Lupus Nephritis Collaborative Study Group. Am. J. Kidney Dis. 2000 35 : 904 914.
13. Bruce IN, Gladman DD, Urowitz MB. Factors associated with refractory renal disease in patients with systemic lupus erythematosus: The role of patient nonadherence. Arthritis Care Res. 2000 13 : 406 408.
14. Ayodele OE, Okpechi IG, Swanepoel CR. Predictors of poor renal outcome in patients with biopsy proven lupus nephritis. Nephrology 2010 15 : 482 490.